This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top 10 Health Care ETFs

IHF (iShares DJ U.S. Health Care Providers ETF) tracks the Dow Jones U.S. Select Healthcare providers Index which measures the health care provider subsector of the U.S. equity market. As such the index contains fewer holdings. The fund was launched in May 2006. The expense ratio is .48%. AUM equal $355 million with average daily trading volume over 145K shares. As of July 2011 the annual dividend is negligible but the YTD return is nearly 19%. 

Data as of July 2011

IHF Top Ten Holdings & Weightings

  1. UnitedHealth Group Inc (UNH): 14.08%
  2. WellPoint, Inc. (WLP): 8.46%
  3. Express Scripts (ESRX): 7.70%
  4. Medco Health Solutions, Inc. (MHS): 6.84%
  5. Aetna, Inc. (AET): 5.41%
  6. Cigna Corporation (CI): 4.69%
  7. Humana (HUM): 4.57%
  8. Laboratory Corporation of America Holdings (LH): 3.50%
  9. Quest Diagnostics, Inc. (DGX): 3.38%
  10. DaVita Inc (DVA): 3.10%

IXJ (iShares S&P Global Health Care ETF) follows the S&P Global Health Care Index including a wide range of companies from biotech, manufacturing, medical devices and pharmaceuticals. The fund was launched in November 2001. The expense ratio is .48%. AUM equal $550 million with average daily trading volume around 60K shares. As of July 2011 the annual dividend was $.80 making the current yield 1.40% with YTD return of 11.50%.

Data as of July 2011

IXJ Top Ten Holdings & Weightings

  1. Johnson & Johnson (JNJ): 7.82%
  2. Novartis AG (NVSEF): 7.42%
  3. Pfizer Inc (PFE): 6.98%
  4. Roche Holding AG (RHHVF): 5.03%
  5. GlaxoSmithKline PLC (GLAXF): 4.73%
  6. Merck & Co Inc (MRK): 4.67%
  7. Sanofi (SAN): 3.78%
  8. Abbott Laboratories (ABT): 3.51%
  9. AstraZeneca PLC (AZN): 2.94%
  10. Bayer AG (BAYN): 2.85%

 

The health care sector has enjoyed a positive first half of 2011 despite so many uncertainties surrounding government health care changes and mandates. There is a lot to choose from in terms of indices linked to ETFs. Some are passive and duplicative relatively. It's essential to remember it's really a game of battleship for sponsors seeking to be first to a sector space or just being competitive in the space. This is their business interest apart from your investment interest. You should always ignore their interests and align your choices with what serves your objectives best.

Investors should note that in a rising market particularly ETFs linked to enhanced issues will tend to outperform conventional index linked issues. I've not done enough analysis to determine their relative performance during down market periods.

New ETFs from highly regarded and substantial new providers are also being issued. These may include Charles Schwab's ETFs and Scottrade's Focus Shares which both are issuing new ETFs with low expense ratios and commission free trading at their respective firms. These may also become popular as they become seasoned. 

For further information about portfolio structures using this or other ETFs see www.etfdigest.com .

You may address any feedback to: feedback@etfdigest.com   

 

(Source for holding data is from ETF Database and from various sponsors.)

This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

Dave Fry is founder and publisher of ETF Digest, Dave's Daily blog and the best-selling book author of Create Your Own ETF Hedge Fund, A DIY Strategy for Private Wealth Management, published by Wiley Finance in 2008. A detailed bio is here: Dave Fry.

4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
FXH $65.56 0.00%
IBB $344.00 0.00%
IYH $153.85 0.00%
PTH $59.14 0.00%
VHT $134.64 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs